Company News
Laurus Labs Invests ₹1,078 Cr in KRKA Pharma
Laurus Labs invested ₹1,078 million in KRKA Pharma via rights issue acquiring 107.8 million shares.
Post-investment, Laurus Labs maintains 49% stake in the joint venture with KRKA d.d., Slovenia.
Disc
